Julie Wilson

15PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

|Sep 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Jennifer J Knox, Grainne O'Kane, Daniel King

|Apr 04, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.

Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue

|Feb 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System.

Felix E G Beaudry, Zhihao Li, Ayelet Borgida

|Mar 06, 2024
Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells.

Tajinder Ubhi, Olga Zaslaver, Andrew T Quaile

|Aug 09, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.

Joan Miguel Romero, Emma Titmuss, Yifan Wang

Pageof 3

Frequent Collaborators

7 joint publications

Grainne O'Kane

7 joint publications

Robert E Denroche

5 joint publications

Robert C Grant

5 joint publications

Marco Marra